Fibulin-3 Regulates Tissue Inhibitor of Metalloproteinases 3 to Inhibit Senescence in Intervertebral Disc Nucleus Pulposus Cells
Abstract
To investigate the effect of fibulin-3 on the senescence of intervertebral disc nucleus pulposus cells (NPCs) through the regulation of tissue inhibitor of metalloproteinases 3 (TIMP-3) expression and to elucidate the molecular mechanisms involved.
Methods
1). The nucleus pulposus tissues and imaging data of 37 patients who had undergone intervertebral disc surgery were collected. The degree of degeneration of the intervertebral discs were classified according to the Pfirrmann grading system. The senescence degree of NPCs was determined using senescence-associated β-galactosidase (SA-β-gal) staining. Fibulin-3 expression levels were determined using Western blot and ELISA. The relationship between fibulin-3 and disc degeneration and NPCs senescence was investigated. 2). Human intervertebral disc NPCs were cultured in vitro. The proliferation and senescence of NPC across continuous passage were observed via CCK-8 assay and SA-β-gal staining, respectively. Fibulin-3 expression levels and the expression of inflammatory cytokines and matrix metalloproteinases were assessed. Exogenous fibulin-3 was added to verify its effect on the proliferation and senescence of NPCs. 3). The effect of fibulin-3 on the apoptosis and proliferation of NPCs was verified through gene overexpression, which was used in combination with an apoptosis inhibitor for bidirectional verification. 4). Bioinformatics analysis was performed to explore the relationship between fibulin-3 and the TIMP family. Experiments overexpressing fibulin-3 and silencing the TIMP-3 gene were performed to verify their role in NPCs senescence.
Results
1). The intervertebral disc degeneration samples from 37 patients were classified according to the Pfirrmann grading system. The higher the degeneration grade, the lower fibulin-3 expression. Spearman correlation analysis showed that the disc grade was negatively correlated with the NPC senescence grade (r=-0.87, P<0.001) and fibulin-3 expression (r=-0.79, P<0.001). 2). As the passage number of NPCs increased, fibulin-3 expression gradually decreased, cell proliferation ability weakened, and the expression of inflammatory cytokines and matrix metalloproteinases increased. After exogenous fibulin-3 was added, cell morphology and growth status were maintained, cell senescence was significantly inhibited, and the expression of inflammatory cytokines and matrix metalloproteinases was markedly reduced. 3). Gene overexpression experiments showed that fibulin-3 reduced NPC apoptosis and promoted cell proliferation, thereby inhibiting NPC senescence. 4). Bioinformatics analysis revealed a significant association between fibulin-3 and TIMP-3 of the TIMP family. Further experiments confirmed that overexpressing fibulin-3 enhanced TIMP-3 expression, while silencing the TIMP-3 gene significantly weakened the inhibitory effect of fibulin-3 on NPCs senescence. This indicates that, through regulating TIMP-3, fibulin-3 inhibits the activity of matrix metalloproteinases, affects the synthesis and degradation of the extracellular matrix, and ultimately inhibits NPCs senescence.
Conclusion
This study demonstrates that fibulin-3 plays a crucial role in inhibiting the senescence of intervertebral disc NPCs by regulating TIMP-3. The specific mechanisms involved are as follows, fibulin-3 upregulates TIMP-3 expression, inhibits matrix metalloproteinase activity, and reduces extracellular matrix degradation, thereby promoting extracellular matrix synthesis. Additionally, fibulin-3 inhibits NPCs senescence by reducing apoptosis and promoting cell proliferation. Therefore, fibulin-3 and TIMP-3 have potential therapeutic significance in maintaining intervertebral disc health and delaying degeneration.
Keywords: Fibulin-3, Nucleus pulposus cells, Intervertebral disc degeneration, Tissue inhibitor of metalloproteinases 3
Full Text:
PDFReferences
SILAGI E S, NOVAIS E J, BISETTO S, et al. Lactate efflux from intervertebral disc cells is required for maintenance of spine health. J Bone Miner Res, 2020, 35(3): 550–570. doi: 10.1002/jbmr.3908.
MCDONNELL E E, WILSON N, BARCELLONA M N, et al. Preclinical to clinical translation for intervertebral disc repair: Effects of species-specific scale, metabolism, and matrix synthesis rates on cell-based regeneration. JOR Spine, 2023, 6(3): e1279. doi: 10.1002/jsp2.1279.
SAMANTA A, LUFKIN T, KRAUS P. Intervertebral disc degeneration-Current therapeutic options and challenges. Front Public Health, 2023, 11: 1156749. doi: 10.3389/fpubh.2023.1156749.
LIVINGSTONE I, UVERSKY VN, FURNISS D, et al. The pathophysiological significance of fibulin-3. Biomolecules, 2020, 10(9): 1294. doi: 10.3390/biom10091294.
GREEN J, TINSON R A J, BETTS J H J. Suramin analogues protect cartilage against osteoarthritic breakdown by increasing levels of tissue inhibitor of metalloproteinases 3 (TIMP-3) in the tissue. Bioorg Med Chem, 2023, 92: 117424. doi: 10.1016/j.bmc.2023.117424.
SHARPLESS N E, SHERR C J. Forging a signature of in vivo senescence. Nat Rev Cancer, 2015, 15(7): 397–408. doi: 10.1038/nrc3960.
Van DEURSEN J M. The role of senescent cells in ageing. Nature, 2014, 509(7501): 439–446. doi: 10.1038/nature13193.
GRUBER H E, INGRAM J A, NORTON H J, et al. Senescence in cells of the aging and degenerating intervertebral disc: immunolocalization of senescence-associated beta-galactosidase in human and sand rat discs. Spine (Phila Pa 1976), 2007, 32(3): 321–327. doi: 10.1097/01.brs. 0000253960.57051.de.
CHO W, PARK J, KIM J, et al. Low-molecular-weight fish collagen peptide prevents osteoarthritis symptoms in chondrocytes and monoiodoacetate-injected rats. Mar Drugs, 2023, 21(12): 608. doi: 10. 3390/md21120608.
MIYAZAKI K, MIYAZAKI S, YURUBE T, et al. Protective effects of growth differentiation factor-6 on the intervertebral disc: an in vitro and in vivo study. Cells, 2022, 11(7): 1174. doi: 10.3390/cells11071174.
LI Y, ZHANG T, TIAN W, et al. Loss of TIMP3 expression induces inflammation, matrix degradation, and vascular ingrowth in nucleus pulposus: A new mechanism of intervertebral disc degeneration. FASEB J, 2020, 34(4): 5483–5498. doi: 10.1096/fj.201902364RR.
PANEBIANCO C J, DAVE A, CHARYTONOWICZ D, et al. Single-cell RNA-sequencing atlas of bovine caudal intervertebral discs: Discovery of heterogeneous cell populations with distinct roles in homeostasi. FASEB J, 2021, 35(11): e21919. doi: 10.1096/fj.202101149R.
OBAYA A J, RUA S, MONCADA-PAZOS A, et al. The dual role of fibulins in tumorigenesis. Cancer Lett, 2012, 325(2): 132–138. doi: 10. 1016/j.canlet.2012.06.019.
TIAN H, LIU J, CHEN J, et al. Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment. Oncogene, 2015, 34(45): 5635–5647. doi: 10.1038/onc.2015.13.
NANDHU M S, HU B, COLE S E, et al. Novel paracrine modulation of Notch-DLL4 signaling by fibulin-3 promotes angiogenesis in high-grade gliomas. Cancer Res, 2014, 74(19): 5435–5448. doi: 10.1158/0008-5472. CAN-14-0685.
JIANG H, QIN H, YANG Q, et al. Effective delivery of miR-150-5p with nucleus pulposus cell-specific nanoparticles attenuates intervertebral disc degeneration. J Nanobiotechnol, 2024, 22(1): 292. doi: 10.1186/s12951-024-02561-x.
HUANG Y, QIU X, LIU J, et al. Identification of biomarkers, pathways, immune properties of mitophagy genes, and prediction models for intervertebral disc degeneration. J Inflamm Res, 2024, 17: 2959–2975. doi: 10.2147/JIR.S461668.
DANIEL S, HULLEMAN J D. Exploring ocular fibulin-3 (EFEMP1): anatomical, age-related, and species perspectives. Biochim Biophys Acta Mol Basis Dis, 2024, 1870(6): 167239. doi: 10.1016/j.bbadis.2024.167239.
KWON W K, MOON H J, KWON T H, et al. The role of hypoxia in angiogenesis and extracellular matrix regulation of intervertebral disc cells during inflammatory reactions. Neurosurgery, 2017, 81(5): 867–875. doi: 10.1093/neuros/nyx149.
Refbacks
- There are currently no refbacks.



